Klingenstein Fields & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,705
Closed -$964K 194
2019
Q3
$964K Sell
9,705
-92,202
-90% -$8.76M 0.05% 114
2019
Q2
$9.42M Buy
101,907
+92
+0.1% +$8.74K 0.49% 63
2019
Q1
$9.61M Sell
101,815
-41,440
-29% -$3.62M 0.52% 65
2018
Q4
$9.18M Sell
143,255
-30,228
-17% -$2.23M 0.39% 65
2018
Q3
$15.5M Sell
173,483
-13,319
-7% -$1.18M 0.56% 54
2018
Q2
$14.8M Buy
186,802
+17,228
+10% +$1.43M 0.57% 55
2018
Q1
$15.1M Buy
169,574
+27,243
+19% +$2.62M 0.58% 52
2017
Q4
$14.9M Sell
142,331
-31,767
-18% -$3.58M 0.55% 54
2017
Q3
$25.4M Sell
174,098
-6,565
-4% -$894K 0.98% 41
2017
Q2
$23.5M Buy
180,663
+12,166
+7% +$1.49M 0.92% 42
2017
Q1
$21M Buy
168,497
+19,685
+13% +$2.36M 0.85% 43
2016
Q4
$17.2M Buy
148,812
+4,451
+3% +$496K 0.75% 47
2016
Q3
$15.1M Buy
144,361
+859
+0.6% +$93K 0.69% 47
2016
Q2
$14.2M Buy
143,502
+6,864
+5% +$710K 0.66% 45
2016
Q1
$13.7M Sell
136,638
-16,447
-11% -$1.69M 0.68% 47
2015
Q4
$18.3M Buy
153,085
+7,287
+5% +$843K 0.91% 39
2015
Q3
$15.8M Buy
145,798
+135,638
+1,335% +$16.8M 0.78% 47
2015
Q2
$1.18M Sell
10,160
-200
-2% -$22.9K 0.05% 120
2015
Q1
$1.19M Sell
10,360
-370
-3% -$44.2K 0.05% 122
2014
Q4
$1.2M Sell
10,730
-4,300
-29% -$453K 0.05% 116
2014
Q3
$1.43M Sell
15,030
-300
-2% -$27.1K 0.06% 116
2014
Q2
$1.32M Sell
15,330
-2,470
-14% -$188K 0.06% 123
2014
Q1
$1.24M Sell
17,800
-83,520
-82% -$6.61M 0.06% 122
2013
Q4
$8.56M Sell
101,320
-6,670
-6% -$528K 0.31% 72
2013
Q3
$8.32M Sell
107,990
-205,470
-66% -$14.4M 0.33% 70
2013
Q2
$18.3M Buy
+313,460
New +$18.9M 0.66% 43

Other funds holding CELG

Klingenstein Fields & Co's CELG Position: Q4 2019 in Review

Klingenstein Fields & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,705 shares — an estimated $964K sold.

Klingenstein Fields & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $25.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Klingenstein Fields & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Klingenstein Fields & Co sold 9,705 Celgene Corp shares in Q4 2019, an estimated $964K.
  • Klingenstein Fields & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Klingenstein Fields & Co's Celgene Corp position peaked at $25.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Klingenstein Fields & Co's 13F filing for Q4 2019, filed 4 Feb 2020.